Message from Chairman

We have come to a golden era of rapid progress in the management of cancer. The striking achievements include biomarker testing using next generation sequencing technologies, liquid biopsies, new targeted agents, immunotherapies and proton therapy. These will form the main themes of the 4th HKiOS this year.

It is not sufficient just to prove that such new treatments can improve the survival and quality of life of our patients. It is equally important to ensure that our patients can have access to such treatments as early as possible – this will involve breaking down of barriers mainly due to the lack of knowledge amongst professionals, health administrators and the community as a whole.

Due to the explosion in knowledge, the first most important task of HKiOS is to educate our fellow colleagues in all related disciplines and to ensure that they are kept abreast of all such new developments. Secondly, we should promote their networking with the more experienced experts in the field and establishment of collaborations between different cancer centres around the world so that they can have first-hand knowledge and opportunities for practice. Thirdly, we should advocate such new treatments and facilitate the health administrators and the community to set priorities in the allocation of resources.

The theme of the first and second HKiOS was on functional imaging and proton therapy respectively. We have been very successful in arousing the attention and interest of our colleagues through their keen participation. The programme of this year has been greatly expanded to accommodate all the new exciting themes. I am looking forward to a fruitful symposium again.

Dr. Joseph Siu-Kie AU
Chairman of the Organizing Committee, HKIOS

Copyright © All Right Reserved